Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, as well as biopharmaceutical products globally. Its generic offerings come in various dosage forms including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. The company also focuses on specialty areas such as central nervous system (CNS) disorders, respiratory conditions, and oncology. Key branded products include COPAXONE for multiple sclerosis, AJOVY for migraine prevention, AUSTEDO for Huntington's disease and tardive dyskinesia, UZEDY for schizophrenia, and respiratory treatments like ProAir RespiClick and QVAR RediHaler for asthma. Additionally, Teva provides active pharmaceutical ingredients and contract manufacturing services.

Teva Pharmaceutical Industries Limited is listed on the New York Stock Exchange (NYSE) under the ticker symbol TEVA. It trades in US Dollars (USD), as it is classified under the US region. The company is headquartered in Israel, but its shares are traded on a major US exchange, making it accessible to international investors.

Teva Pharmaceutical Industries operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. This means the company is primarily involved in the development and production of both generic medications (which are bioequivalent to brand-name drugs) and specialty pharmaceuticals that target specific therapeutic areas such as central nervous system disorders, respiratory diseases, and oncology. As a generic and specialty drug manufacturer, Teva competes with other pharmaceutical companies by offering affordable alternatives to branded drugs while also innovating in niche therapeutic fields.

Teva Pharmaceutical Industries Limited is headquartered in Israel, but it serves markets globally. The company's description indicates that it develops, manufactures, markets, and distributes its products worldwide. While the exact geographic breakdown is not provided, the company's portfolio includes products approved in multiple regions, such as the US and Europe. Teva's global presence allows it to supply generic and specialty medicines to patients and healthcare providers across many countries, leveraging its manufacturing and distribution capabilities.

Teva's product portfolio includes both generic and branded medicines across several therapeutic areas. In the central nervous system (CNS) space, key products are COPAXONE for relapsing forms of multiple sclerosis, AJOVY for migraine prevention, AUSTEDO for chorea associated with Huntington's disease and tardive dyskinesia, and UZEDY for schizophrenia. For respiratory conditions, Teva offers ProAir RespiClick and QVAR RediHaler for asthma, BRALTUS (a long-acting muscarinic antagonist), DuoResp Spiromax, and AirDuo RespiClick. In oncology, it provides BENDEKA and TREANDA injections for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. The company also has an out-licensing platform and offers over-the-counter products under the SUDOCREM brand.